KIT and breast phyllodes tumor: It is mainly consistent with the previous study by Liu et al,[19] who reported similar changes for CD34, CD10, and CD117 in the pathological diagnosis of breast phyllodes tumors and other individual reports,[20,21] suggesting that although various previously reported immunohistochemical indices overlapped in FA and different grades of PT, none of the indices had a unique diagnostic value.